platoseedplatoseed
Blood testing device for early diagnosis of cancer and treatment…
Delee is a medical device company that developed a blood-testing device for early diagnosis of cancer and treatment monitoring through the isolation and analysis of the circulating tumor cells.
Delee appears to position itself as a provider related to a blood testing device for early cancer diagnosis and treatment, though the supplied website text predominantly describes an online gaming site with unrelated content. The available content for Delee is minimal and does not clearly outline a concrete product or business model beyond the one-liner mention.
Not enough information in the provided text to describe a concrete product or how it works. The site text focuses on an online gaming platform rather than a blood testing device.
Who it’s for: Not identifiable from the provided text.
Co-Founder and acting CEO at Delee Corp. Velarde has been responsible for the development and execution of the company's strategic plans. Velarde's outstanding work has been highly regarded by international institutions such as Cartier Women's Initiative Awards and WeXchange (from the Inter-American Development Bank). She also lead and supervised the development of the Zen FluidicsTM scientific line, a group of products that enables researchers to develop their own microfluidic applications.
Formerly “Semka Technologies” · why startups rename →
Rapid, scalable diagnostic for SARS-CoV-2 and beyond
Our tests help eradicate cancer by telling doctors whether they got…
